AAAAAA

   
Results: 1-25 | 26-36
Results: 1-25/36
EFFICACY AND TOLERABILITY OF IRBESARTAN, AN ANGIOTENSIN-II RECEPTOR ANTAGONIST, IN PRIMARY HYPERTENSION - A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-TITRATION STUDY
Authors: GUTHRIE R SAINI R HERMAN T PLESKOW W SPRECHER D COLLINS G
Citation: R. Guthrie et al., EFFICACY AND TOLERABILITY OF IRBESARTAN, AN ANGIOTENSIN-II RECEPTOR ANTAGONIST, IN PRIMARY HYPERTENSION - A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-TITRATION STUDY, Clinical drug investigation, 15(3), 1998, pp. 217-227
FLUOROQUINOLONES IN FAMILY-PRACTICE
Authors: GUTHRIE R
Citation: R. Guthrie, FLUOROQUINOLONES IN FAMILY-PRACTICE, Infectious diseases in clinical practice, 7, 1998, pp. 203-205
TREATING PATIENTS WITH DOCUMENTED ATHEROSCLEROSIS TO NATIONAL CHOLESTEROL EDUCATION PROGRAM-RECOMMENDED LOW-DENSITY-LIPOPROTEIN CHOLESTEROLGOALS WITH ATORVASTATIN, FLUVASTATIN, LOVASTATIN AND SIMVASTATIN
Authors: BROWN AS BAKKERARKEMA RG YELLEN L HENLEY RW GUTHRIE R CAMPBELL CF KOREN M WOO W MCLAIN R
Citation: As. Brown et al., TREATING PATIENTS WITH DOCUMENTED ATHEROSCLEROSIS TO NATIONAL CHOLESTEROL EDUCATION PROGRAM-RECOMMENDED LOW-DENSITY-LIPOPROTEIN CHOLESTEROLGOALS WITH ATORVASTATIN, FLUVASTATIN, LOVASTATIN AND SIMVASTATIN, Journal of the American College of Cardiology, 32(3), 1998, pp. 665-672
AN ELECTIVE-TITRATION STUDY OF THE COMPARATIVE EFFECTIVENESS OF 2 ANGIOTENSIN-II RECEPTOR BLOCKERS, IRBESARTAN AND LOSARTAN
Authors: OPARIL S GUTHRIE R LEWIN AJ MARBURY T REILLY K TRISCARI J WITCHER JA
Citation: S. Oparil et al., AN ELECTIVE-TITRATION STUDY OF THE COMPARATIVE EFFECTIVENESS OF 2 ANGIOTENSIN-II RECEPTOR BLOCKERS, IRBESARTAN AND LOSARTAN, Clinical therapeutics, 20(3), 1998, pp. 398-409
EVOLUTION IS NOT GOAL-ORIENTED
Authors: GUTHRIE R
Citation: R. Guthrie, EVOLUTION IS NOT GOAL-ORIENTED, The Futurist, 32(2), 1998, pp. 4-4
STAGED DIABETES MANAGEMENT - AN EFFECTIVE TOOL FOR MANAGEMENT OF TYPE-2 DIABETES BY DIABETES EDUCATORS AND PRIMARY-CARE PHYSICIANS
Authors: BLONDE L GUTHRIE R TAN M PARKES J OBRIEN T GINSBERG B
Citation: L. Blonde et al., STAGED DIABETES MANAGEMENT - AN EFFECTIVE TOOL FOR MANAGEMENT OF TYPE-2 DIABETES BY DIABETES EDUCATORS AND PRIMARY-CARE PHYSICIANS, Diabetologia, 41, 1998, pp. 149-149
DIABETES PREVALENCE, DEVELOPMENT, AND PROGRESSION
Authors: KELLEY D VODOOR M ZONSZEIN J HENRY RR GARBER J GUTHRIE R GLEESON J KODAKIMBLE MA DIPETTE DJ PETERS AL
Citation: D. Kelley et al., DIABETES PREVALENCE, DEVELOPMENT, AND PROGRESSION, American journal of managed care, 3, 1997, pp. 12-25
DIABETES MANAGEMENT-TECHNIQUES - ROUND-TABLE DISCUSSION
Authors: PETERS AL GARBER J HENRY RR GUTHRIE R VODOOR M GLEESON J ZONSZEIN J KELLEY D ETTINGER B DIPETTE DJ
Citation: Al. Peters et al., DIABETES MANAGEMENT-TECHNIQUES - ROUND-TABLE DISCUSSION, American journal of managed care, 3, 1997, pp. 26-39
DOXAZOSIN FOR BENIGN PROSTATIC HYPERPLASIA IN PRIMARY-CARE
Authors: GUTHRIE R
Citation: R. Guthrie, DOXAZOSIN FOR BENIGN PROSTATIC HYPERPLASIA IN PRIMARY-CARE, Clinical therapeutics, 19(6), 1997, pp. 1269-1277
MULTIVARIATE PROFILE OF SMOKING IN SOUTHEAST-ASIAN MEN - A BIOCHEMICALLY VERIFIED ANALYSIS
Authors: MOESCHBERGER ML ANDERSON J KUO YF CHEN MS WEWERS ME GUTHRIE R
Citation: Ml. Moeschberger et al., MULTIVARIATE PROFILE OF SMOKING IN SOUTHEAST-ASIAN MEN - A BIOCHEMICALLY VERIFIED ANALYSIS, Preventive medicine, 26(1), 1997, pp. 53-58
BENIGN PROSTATIC HYPERPLASIA IN ELDERLY MEN - WHAT ARE THE SPECIAL ISSUES IN TREATMENT
Authors: GUTHRIE R
Citation: R. Guthrie, BENIGN PROSTATIC HYPERPLASIA IN ELDERLY MEN - WHAT ARE THE SPECIAL ISSUES IN TREATMENT, Postgraduate medicine, 101(5), 1997, pp. 141
PHYSICIANS OFFICE EVALUATION OF A NEW 7-MINUTE QUANTITATIVE ASSAY FORURINARY ALBUMIN AND CREATININE
Authors: GUTHRIE R HIAR C KILO C CHILDS B FISHER R PINSON M PARKER D
Citation: R. Guthrie et al., PHYSICIANS OFFICE EVALUATION OF A NEW 7-MINUTE QUANTITATIVE ASSAY FORURINARY ALBUMIN AND CREATININE, Diabetologia, 40, 1997, pp. 2094-2094
DIABETES DISEASE STATE MANAGEMENT BY DIABETES EDUCATORS IN MANAGED CARE
Authors: BLONDE L GUTHRIE R PARKES JL GINSBERG BH
Citation: L. Blonde et al., DIABETES DISEASE STATE MANAGEMENT BY DIABETES EDUCATORS IN MANAGED CARE, Diabetologia, 40, 1997, pp. 2587-2587
DIABETES DISEASE STATE MANAGEMENT BY DIABETES EDUCATORS IN MANAGED CARE
Authors: BLONDE L GUTHRIE R PARKES JL GINSBERG BH
Citation: L. Blonde et al., DIABETES DISEASE STATE MANAGEMENT BY DIABETES EDUCATORS IN MANAGED CARE, Diabetes, 46, 1997, pp. 239-239
IDENTIFICATION OF A SMALL-MOLECULE INHIBITOR OF THE IL-2 IL-2R-ALPHA RECEPTOR INTERACTION WHICH BINDS TO IL-2/
Authors: TILLEY JW CHEN L FRY DC EMERSON SD POWERS GD BIONDI D VARNELL T TRILLES R GUTHRIE R MENNONA F KAPLAN G LEMAHIEU RA CARSON M HAN RJ LIU CM PALERMO R JU G
Citation: Jw. Tilley et al., IDENTIFICATION OF A SMALL-MOLECULE INHIBITOR OF THE IL-2 IL-2R-ALPHA RECEPTOR INTERACTION WHICH BINDS TO IL-2/, Journal of the American Chemical Society, 119(32), 1997, pp. 7589-7590
EFFICACY AND SAFETY OF FOSINOPRIL HYDROCHLOROTHIAZIDE COMBINATIONS ONAMBULATORY BLOOD-PRESSURE PROFILES IN HYPERTENSION/
Authors: GUTHRIE R REGGI DR PLESHER MM SAINI RK BATTIKHA JP
Citation: R. Guthrie et al., EFFICACY AND SAFETY OF FOSINOPRIL HYDROCHLOROTHIAZIDE COMBINATIONS ONAMBULATORY BLOOD-PRESSURE PROFILES IN HYPERTENSION/, American journal of hypertension, 9(4), 1996, pp. 306-311
INTRODUCTION OF NEWBORN SCREENING FOR PHENYLKETONURIA - A PERSONAL HISTORY
Authors: GUTHRIE R
Citation: R. Guthrie, INTRODUCTION OF NEWBORN SCREENING FOR PHENYLKETONURIA - A PERSONAL HISTORY, European journal of pediatrics, 155, 1996, pp. 4-5
HYPERTENSION AMONG PATIENTS WITH TYPE-II DIABETES IN REFERRAL AND PRIMARY-CARE CLINICS
Authors: MOORE W BRENNER A CHILDS B GUTHRIE R TATPATI O HOFFMAN J FREDRICKSON D
Citation: W. Moore et al., HYPERTENSION AMONG PATIENTS WITH TYPE-II DIABETES IN REFERRAL AND PRIMARY-CARE CLINICS, Diabetes, 45, 1996, pp. 985-985
A 'LETTER TO JAMES BALDWIN'
Authors: GUTHRIE R
Citation: R. Guthrie, A 'LETTER TO JAMES BALDWIN', Chicago review, 42(1), 1996, pp. 59-62
VASCULAR HYPERTROPHY IS AN EARLY FINDING IN ESSENTIAL-HYPERTENSION AND IS RELATED TO ARTERIAL-PRESSURE WAVE-FORM CONTOUR
Authors: TICE FD PETERSON JW ORSINELLI DA BINKLEY PF CODY RJ GUTHRIE R PEARSON AC
Citation: Fd. Tice et al., VASCULAR HYPERTROPHY IS AN EARLY FINDING IN ESSENTIAL-HYPERTENSION AND IS RELATED TO ARTERIAL-PRESSURE WAVE-FORM CONTOUR, The American heart journal, 132(3), 1996, pp. 621-627
TERAZOSIN FOR BPH - REPLY
Authors: GUTHRIE R
Citation: R. Guthrie, TERAZOSIN FOR BPH - REPLY, Journal of family practice, 40(3), 1995, pp. 222-223
DOUBLE-BLIND DEVELOPMENTAL EVALUATION AT 1-YEAR CORRECTED AGE OF 597 PREMATURE-INFANTS WITH BIRTH WEIGHTS FROM 500 TO 1350 GRAMS ENROLLED IN 3 PLACEBO-CONTROLLED TRIALS OF PROPHYLACTIC SYNTHETIC SURFACTANT
Authors: CORBET A LONG W SCHUMACHER R GERDES J COTTON R ANDAY E BOROS S BOSE C BUCCIARELLI R BURCHFIELD D COOK LN COURTNEY S DERLETH D DHANIREDDY R EASA D GOLDMAN S GONG A GUTHRIE R LEBLANC M MAMMEL M MCGUINESS G MULLETT M PAULY T PRAMANIK AK SELL M STEVENSON D SUNDELL H THOMPSON T VAUGHAN R VOLBERG F WALTER D WALTHER F
Citation: A. Corbet et al., DOUBLE-BLIND DEVELOPMENTAL EVALUATION AT 1-YEAR CORRECTED AGE OF 597 PREMATURE-INFANTS WITH BIRTH WEIGHTS FROM 500 TO 1350 GRAMS ENROLLED IN 3 PLACEBO-CONTROLLED TRIALS OF PROPHYLACTIC SYNTHETIC SURFACTANT, The Journal of pediatrics, 126(5), 1995, pp. 5-12
ONE-YEAR FOLLOW-UP OF 66 PREMATURE-INFANTS WEIGHING 500 TO 699 GRAMS TREATED WITH A SINGLE-DOSE OF SYNTHETIC SURFACTANT OR AIR PLACEBO AT BIRTH - RESULTS OF A DOUBLE-BLIND TRIAL
Authors: WALTHER FJ MULLETT M SCHUMACHER R SUNDELL H EASA D LONG W ANDAY E BOROS S BOSE C BUCCIARELLI R BURCHFIELD D COOK LN CORBET A COTTON R COURTNEY S DERLETH D DHANIREDDY R GERDES J GOLDMAN S GONG A GUTHRIE R LEBLANC M MAMMEL M MCGUINESS G MULLET M PAULY T PRAMANIK AK SELL M STEVENSON D THOMPSON T VAUGHAN R VOLBERG F WALTER D WALTHER F
Citation: Fj. Walther et al., ONE-YEAR FOLLOW-UP OF 66 PREMATURE-INFANTS WEIGHING 500 TO 699 GRAMS TREATED WITH A SINGLE-DOSE OF SYNTHETIC SURFACTANT OR AIR PLACEBO AT BIRTH - RESULTS OF A DOUBLE-BLIND TRIAL, The Journal of pediatrics, 126(5), 1995, pp. 13-19
ONE-YEAR FOLLOW-UP OF 273 INFANTS WITH BIRTH WEIGHTS OF 700 TO 1100 GRAMS AFTER PROPHYLACTIC TREATMENT OF RESPIRATORY-DISTRESS SYNDROME WITH SYNTHETIC SURFACTANT OR AIR PLACEBO
Authors: SELL M COTTON R HIRATA T GUTHRIE R LEBLANC M MAMMEL M LONG W ANDAY E BOROS S BOSE C BUCCIARELLI R BURCHFIELD D COOK LN CORBET A COURTNEY S DERLETH D DHANIREDDY R EASA D GERDES J GOLDMAN S GONG A MCGUINESS G MULLETT M PAULY T PRAMANIK AK SCHUMACHER R STEVENSON D SUNDELL H THOMPSON T VAUGHAN R VOLBERG F WALTER D WALTHER F
Citation: M. Sell et al., ONE-YEAR FOLLOW-UP OF 273 INFANTS WITH BIRTH WEIGHTS OF 700 TO 1100 GRAMS AFTER PROPHYLACTIC TREATMENT OF RESPIRATORY-DISTRESS SYNDROME WITH SYNTHETIC SURFACTANT OR AIR PLACEBO, The Journal of pediatrics, 126(5), 1995, pp. 20-25
HEALTH AND NEURODEVELOPMENTAL OUTCOME AT 1-YEAR ADJUSTED AGE IN 508 INFANTS WEIGHING 700 TO 1100 GRAMS WHO RECEIVED PROPHYLAXIS WITH ONE VERSUS 3 DOSES OF SYNTHETIC SURFACTANT
Authors: GERDES J GERDES M BEAUMONT E COOK L DHANIREDDY R KOPLEMAN A JARRETT R LONG W ANDAY E BOROS S BOSE C BUCCIARELLI R BURCHFIELD D COOK LN CORBET A COTTON R COURTNEY S DERLETH D EASA D GOLDMAN S GONG A GUTHRIE R LEBLANC M MAMMEL M MCGUINESS G MULLETT M PAULY T PRAMANIK AK SCHUMACHER R SELL M STEVENSON D SUNDELL H THOMPSON T VAUGHAN R VOLBERG F WALTER D WALTHER F AVILA E BERRY D BUCHTER S KANAREK K KOPELMAN AE PHILIPS J PURI A ROSENBERG A
Citation: J. Gerdes et al., HEALTH AND NEURODEVELOPMENTAL OUTCOME AT 1-YEAR ADJUSTED AGE IN 508 INFANTS WEIGHING 700 TO 1100 GRAMS WHO RECEIVED PROPHYLAXIS WITH ONE VERSUS 3 DOSES OF SYNTHETIC SURFACTANT, The Journal of pediatrics, 126(5), 1995, pp. 26-32
Risultati: 1-25 | 26-36